Startup India Government of India
Genetoprotein Private Limited - paper in Lucknow, Uttar Pradesh, India. Directors, charges & compliance details.
Revenue · FY 2025
₹1.85 Cr
▲ 81% YoY
Net profit · FY 2025
₹6.92 Lakh
Net margin 3.7%
EBITDA · FY 2025
₹15.9 Lakh
EBITDA margin 8.6%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Brands
1
Associated brands
About Genetoprotein Private Limited
Data last updated:
Genetoprotein Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the paper and packaging sector. It was incorporated on 09 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U21004UP2020PTC137728.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors Shradha Goenka and Jhansi Rani Anishetty.
Its last annual general meeting (AGM) was held on 26 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Director Design Centre D6 Lawrence Terrace, Lucknow, Uttar Pradesh, India – 226001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.85 Cr, a growth of 81% compared to the previous year. For the same year it recorded a net profit of ₹6.92 Lakh (net margin 3.7%) and EBITDA of ₹15.9 Lakh (EBITDA margin 8.6%). Revenue has grown at a compounded annual rate (CAGR) of 97% over three years.
The company is associated with 1 brand: Gene to Protein.
Genetoprotein Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-50-0046835). For more details, the company can be reached via its website genetoprotein.com.
Company Details of Genetoprotein Private Limited
CIN U21004UP2020PTC137728
Registration Number 137728
Incorporation Date 09 November 2020
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 26 September 2025
Date of Balance Sheet 31 March 2024
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-UP-50-0046835
CIN History of Genetoprotein Private Limited
Genetoprotein has one previous CIN (Corporate Identification Number): U24299UP2020PTC137728. The current CIN is U21004UP2020PTC137728, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U21004UP2020PTC137728 | Current |
| U24299UP2020PTC137728 | Previous |
Recognitions & Rankings of Genetoprotein
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-50-0046835
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressDirector Design Centre D6 Lawrence Terrace, Lucknow, Uttar Pradesh, India – 226001
- IndustryPaper, Manufacturing, Paper & Paper Products
Comprehensive company report
Genetoprotein Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Genetoprotein Private Limited
Genetoprotein operates one associated brand: Gene to Protein. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Enzymes, kits, and biochemicals are supplied to life science researchers. | genetoprotein.com |
Business Activity of Genetoprotein Private Limited
The main business activity of Genetoprotein is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Genetoprotein Private Limited FY 2024 filings available
Genetoprotein Private Limited reported revenue of ₹1.85 Cr (up 81% YoY) for FY 2025.
Revenue · FY 2025
₹1.85 Cr ▲ 81%
Net profit · FY 2025
₹6.92 Lakh margin 3.7%
EBITDA · FY 2025
₹15.9 Lakh margin 8.6%
Compounded Annual Growth Rate (CAGR) of Genetoprotein Private Limited
Revenue CAGR growth
1 year
▲ 81%
3 years · compounded
▲ 97%
EBITDA CAGR growth
1 year
▲ 9%
3 years · compounded
▲ 53%
Revenue has grown at a compounded annual rate (CAGR) of 97% over three years, including 81% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Genetoprotein Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹15.9 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6.92 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Genetoprotein Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.6% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Genetoprotein are in the company report.
Premium access
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Genetoprotein Private Limited
Genetoprotein has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shradha Goenka | Director | 09 Nov 2020 | 5 Years 11 Months | Current |
| Jhansi Rani Anishetty | Director | 09 Nov 2020 | 5 Years 11 Months | Current |
Peer Comparison of Genetoprotein Private Limited
Genetoprotein Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bioheaven 360 Genotec Private Limited | ₹1.86 Cr (FY 2024) | •••• | •••• | 79.0% | •••• | New Delhi, Delhi, India |
| Koki Paints Private Limited | ₹1.86 Cr (FY 2025) | •••• | •••• | 35.0% | •••• | Kolkata, West Bengal, India |
| Jyotishri Pharmaceuticals Private Limited | ₹1.86 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Kanpur, Uttar Pradesh, India |
| Sadashivaya Pharma Industries Private Limited | ₹1.86 Cr (FY 2024) | •••• | •••• | 63.0% | •••• | Haridwar, Uttarakhand, India |
| Drakt Marketing Pvt. Ltd. | ₹1.85 Cr (FY 2022) | •••• | •••• | 4.0% | •••• | Kolkata, West Bengal, India |
| Genetoprotein Private Limited this company | ₹1.85 Cr (FY 2025) | •••• | •••• | 81.0% | •••• | Lucknow, Uttar Pradesh, India |
| Pillcraft Private Limited | ₹1.85 Cr (FY 2025) | •••• | •••• | 24.0% | •••• | Mumbai, Maharashtra, India |
| Venkatasai Lifesciences Private Limited | ₹1.85 Cr (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Linear Floor Protections Private Limited | ₹1.85 Cr (FY 2025) | •••• | •••• | -32.0% | •••• | Ghaziabad, Uttar Pradesh, India |
| Shri Maruti Chem Enterprise Private Limited | ₹1.85 Cr (FY 2022) | •••• | •••• | 521.0% | •••• | Mumbai, Maharashtra, India |
| Arboretum Mydroz Pharmaceutical Private Limited | ₹1.85 Cr (FY 2025) | •••• | •••• | 13.0% | •••• | Sri Ganganagar, Rajasthan, India |
Peers are the five companies nearest above and the five nearest below Genetoprotein by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Genetoprotein Private Limited
Genetoprotein Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Genetoprotein Private Limited
Employment history and EPFO contributions of people linked to Genetoprotein.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Genetoprotein Private Limited
Genetoprotein Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Manish Sharma ceased to be Director on 04 Dec 2025.
Ceased
Manish Sharma ceased to be Director.
AGM
Genetoprotein Private Limited last Annual general meeting of members was held on 26 Sep 2025 as per latest MCA records.
Filing
Genetoprotein Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur.
Appointed
Jhansi Rani Anishetty was appointed as Director.
Appointed
Shradha Goenka was appointed as Director.
Incorporation
09 Nov 2020
Genetoprotein Private Limited was registered on 09 Nov 2020 with Roc Kanpur & aged 5 years 11 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Genetoprotein Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Genetoprotein Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Genetoprotein Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Genetoprotein Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Genetoprotein Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genetoprotein Private Limited
Genetoprotein is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in manufacturing, within the paper industry. It was incorporated on 09 November 2020 (6+ years old) and is registered under CIN U21004UP2020PTC137728.
Genetoprotein reported revenue of ₹1.85 Cr for FY 2025 (up 81% YoY).
Genetoprotein has 2 current directors:
- Shradha Goenka - Director
- Jhansi Rani Anishetty - Director
Genetoprotein reported a net profit of ₹6.92 Lakh (net margin 3.7%) and EBITDA of ₹15.9 Lakh (EBITDA margin 8.6%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Genetoprotein is 97% over three years. In the latest year (FY 2025) revenue rose 81%. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Genetoprotein is U21004UP2020PTC137728. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genetoprotein was incorporated on 09 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Genetoprotein by revenue are Bioheaven 360 Genotec Private Limited, Koki Paints Private Limited, Jyotishri Pharmaceuticals Private Limited, Sadashivaya Pharma Industries Private Limited, Drakt Marketing Pvt. Ltd. and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Manish Sharma ceased to be Director on 04 Dec 2025. Jhansi Rani Anishetty was appointed as Director on 09 Nov 2020. Shradha Goenka was appointed as Director on 09 Nov 2020.
Yes, Genetoprotein is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Genetoprotein is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-50-0046835).